CN101732634A - Chinese medicament for treating silicosis - Google Patents
Chinese medicament for treating silicosis Download PDFInfo
- Publication number
- CN101732634A CN101732634A CN201010100840A CN201010100840A CN101732634A CN 101732634 A CN101732634 A CN 101732634A CN 201010100840 A CN201010100840 A CN 201010100840A CN 201010100840 A CN201010100840 A CN 201010100840A CN 101732634 A CN101732634 A CN 101732634A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- radix
- grams
- silicosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicament for treating silicosis, which consists of the following raw material medicaments in part by weight: 3 to 7 parts of danshen root, 3 to 7 parts of cherokee rose fruit, 3 to 7 parts of common selfheal fruit-spike, 3 to 7 parts of platycodon root, 3 to 7 parts of hawthorn fruit, 3 to 7 parts of common bletilla pseudobulb, 3 to 7 parts of sessile stemona root, 3 to 7 parts of coastal glehnia root, 3 to 7 parts of vine of multiflower knotweed, 2 to 6 parts of combined spicebush root, 2 to 6 parts of whiteflower hogfennel root, 2 to 6 parts of hairyvein agrimonia herb and bud, 2 to 6 parts of liquoric root, 2 to 6 parts of earthworm, 2 to 6 parts of grassleaf sweelflag rhizome, 2 to 6 parts of chicken's gizzard-membrane, 2 to 6 parts of manchurian wildginger and 2 to 6 parts of common scouring rush herb. The Chinese medicament for treating the silicosis has the effects of activating blood and dissolving stasis, resolving hard lump, dispelling wind damp, disinhibiting water and dispersing swelling, clearing heat and detoxicating, moistening the lung and suppressing cough, lowing sputum consistency and promoting sputum excretion, and has the effects of improving cardio-pulmonary functions. The Chinese medicament has pure Chinese medicinal components and has the characteristics of reasonable formula, simple and convenient administration, obvious treatment effect and the like. 50 clinical application cases prove that total effective rate of the medicament reaches 96 percent.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of anthraco-silicosis.
Background technology
The dust of silicon dioxide is commonly called as silicious dust, it be pathogenecity very strong, to the dust of health hazard maximum.Silicon dioxide grit (silicious dust) sucks behind the alveolar by huge biting to be engulfed in thin, causes the phagocyte lysosome to break.Activate fibroblast, cause the collagen fiber deposition, the lung tissue fibrosis.
Pneumosilicosis is a kind of of pneumoconiosis, is serious occupation disease.Free silica dust is piled up on people's alveolar by respiratory tract, influences gas exchange, and descendant's alveolar is ineffective, the whole fibrosiss of lung tissue.Words with common people say that lung becomes a lump of earth.
Clinical manifestation has 3 kinds of forms: chronic pneumosilicosis, acute silicosis and marginal acceleration pneumosilicosis, these two kinds of clinical manifestation forms significantly concern with contacting dust concentration, pneumosilicosis content and connect dirt year existence, and be the most common with chronic pneumosilicosis at bed.
General early stage can be asymptomatic or symptom is not obvious, along with multiple symptom can appear in the progress of the state of an illness.Symptom does not have specificity, and the symptom weight is often inconsistent with the pneumosilicosis pathological changes.Appearance is early often advanced in tachypnea, is carrying out property and increases the weight of.Uncomfortable in chest, the chest pain of early stage normal sense, chest pain is slighter, is distending pain, dull pain or twinge, and is irrelevant with breathing, body position and work.Degree with tachypnea uncomfortable in chest is relevant with the scope and the character of pathological changes.Early stage because irritable cough can appear in the suction silicious dust, accompanying infection or smoker can have expectoration.Small number of patients has bloody sputum.Can spit blood repeatedly or in a large number when merging pulmonary tuberculosis, pulmonary carcinoma or bronchiectasis.Patient Shang Ke has symptoms such as giddy, weak, insomnia, cardiopalmus, anorexia.
But early stage pneumosilicosis absence of signs.Produce corresponding sign along with the appearance of disease progression and complication.III phase pneumosilicosis causes bronchus displacement and dull percussion note because masses of fibresization is shunk lung tissue.If concurrent chronic bronchitis, emphysema and pulmonary heart disease can have corresponding sign.
The Ministry of Public Health expert once said pneumosilicosis patient's lavation treatment: patient's general anesthesia, and the flushing of pouring water in the lung, the water that comes out is muddy, leaves standstill a period of time, water can be divided into water and silt is two-layer.
At present, the whole world does not have to cure the specific drug of pneumosilicosis.
Summary of the invention
Technical problem to be solved by this invention provides a kind of Chinese medicine for the treatment of anthraco-silicosis.
The present invention seeks to be achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of anthraco-silicosis is made up of following raw material medicaments in part by weight: 3～7 parts of Radix Salviae Miltiorrhizaes, 3～7 parts of Fructus Rosae Laevigatae, 3～7 parts of Spica Prunellaes, 3～7 parts of Radix Platycodoniss, 3～7 parts of Fructus Crataegis, 3～7 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 3～7 parts of the Radixs Stemonae, 3～7 parts of Radix Glehniaes, 3～7 parts of Caulis Polygoni Multiflori, 2～6 parts of the Radixs Linderae, 2～6 parts of Radix Peucedanis, 2～6 parts of Herba Agrimoniaes, 2～6 parts in Radix Glycyrrhizae, 2～6 parts of Pheretimas, 2～6 parts of Rhizoma Acori Graminei, 2～6 parts of Endothelium Corneum Gigeriae Galli, 2～6 parts of Herba Asaris, 2～6 parts of Herba Equiseties Hiemalis.
With above-mentioned raw materials medicine mix homogeneously after sterilizing, after drying, the pulverizing, make powder again.It is oral to be used for the patient.
Above-mentioned all crude drug are the conventional Chinese medicine material, all are documented in Chinese Pharmacopoeia.
The present invention just is being based on the traditional Chinese medical science to pathogenetic research of anthraco-silicosis and Therapeutic Principle, with reference to the scientific achievement of modern pharmacological research to the treatment by Chinese herbs anthraco-silicosis, by the theory of Chinese medical science prescription, from Chinese herbal medicine, screen, meticulous compatibility, make medicine more direct, fast, fully act on focus, Special medicine for special disease, dialectical executing controlled, and be safe and reliable.
Anthraco-silicosis belongs to Chinese medicine " the syndrome of dyspnea ", " cough ", " pulmonary distension " category.Because of making carrying out property of the state of an illness, patient's repeated infection increases the weight of.This disease beginning influences taste, the later stage and the heart then at lung.Can form pathologic products such as expectorant, drink, addiction in the course of disease, be specimen, deficiency and excess furthermore card or influence each other mutually eventually.The silicotic causes hypertrophy such as capillary bronchus, alveolar wall, interstitial lung connective tissue and blood capillary because of repeated infection.Secular edema, hyperemia, secretions increase and chronic inflammatory damage, swelling compressing capillary network cause that blood is anvil, coagulates, state such as poly-.In view of the above, according to theory of Chinese medical science, adopt that depressed lung-energy dispersing, ventilation are invigorated blood circulation, mass dissipating and swelling eliminating, heat-clearing and toxic substances removing, collateral dredging reduce phlegm therapy.
The Chinese medicine of treatment anthraco-silicosis provided by the invention, have that invigorating blood circulation is tired, hard masses softening and resolving, wind-damp dispelling, inducing diuresis to remove edema, heat-clearing and toxic substances removing, nourishing the lung to arrest cough, low sputum kills denseness and promotes sputum discharge effect, and can improve the gas dispersion function, correct the anoxia of body, have the effect of improving cardio-pulmonary function.Characteristics such as the present invention is pure Chinese medicine ingredients, has reasonable recipe, and medication is simple and convenient, and therapeutic effect is obvious are used case 50 examples clinically, and total effective rate reaches 96%.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
Embodiment 1
Take by weighing Radix Salviae Miltiorrhizae 3 grams, Fructus Rosae Laevigatae 7 grams, Spica Prunellae 3 grams, Radix Platycodonis 7 grams, Fructus Crataegi 3 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 7 grams, the Radix Stemonae 3 grams, Radix Glehniae 7 grams, Caulis Polygoni Multiflori 3 grams, the Radix Linderae 6 grams, Radix Peucedani 2 grams, Herba Agrimoniae 6 grams, Radix Glycyrrhizae 2 grams, Pheretima 6 grams, Rhizoma Acori Graminei 2 grams, Endothelium Corneum Gigeriae Galli 6 grams, Herba Asari 2 grams, Herba Equiseti Hiemalis's 6 grams respectively.
With above-mentioned raw materials medicine mix homogeneously after sterilizing, after drying, the pulverizing, make powder again.
Embodiment 2
Take by weighing Radix Salviae Miltiorrhizae 7 grams, Fructus Rosae Laevigatae 3 grams, Spica Prunellae 7 grams, Radix Platycodonis 3 grams, Fructus Crataegi 7 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 3 grams, the Radix Stemonae 7 grams, Radix Glehniae 3 grams, Caulis Polygoni Multiflori 7 grams, the Radix Linderae 2 grams, Radix Peucedani 6 grams, Herba Agrimoniae 2 grams, Radix Glycyrrhizae 6 grams, Pheretima 2 grams, Rhizoma Acori Graminei 6 grams, Endothelium Corneum Gigeriae Galli 2 grams, Herba Asari 6 grams, Herba Equiseti Hiemalis's 2 grams respectively.
With above-mentioned raw materials medicine mix homogeneously after sterilizing, after drying, the pulverizing, make powder again.
With embodiment 1 or embodiment 2 prepared powders, be applied to clinical, every day twice, one time 10 gram.Use case 50 examples clinically, total effective rate reaches 96%.
Claims (1)
1. a Chinese medicine for the treatment of anthraco-silicosis is made up of following raw material medicaments in part by weight: 3～7 parts of Radix Salviae Miltiorrhizaes, 3～7 parts of Fructus Rosae Laevigatae, 3～7 parts of Spica Prunellaes, 3～7 parts of Radix Platycodoniss, 3～7 parts of Fructus Crataegis, 3～7 parts of Pseudobulbus Bletillae (Rhizoma Bletillae), 3～7 parts of the Radixs Stemonae, 3～7 parts of Radix Glehniaes, 3～7 parts of Caulis Polygoni Multiflori, 2～6 parts of the Radixs Linderae, 2～6 parts of Radix Peucedanis, 2～6 parts of Herba Agrimoniaes, 2～6 parts in Radix Glycyrrhizae, 2～6 parts of Pheretimas, 2～6 parts of Rhizoma Acori Graminei, 2～6 parts of Endothelium Corneum Gigeriae Galli, 2～6 parts of Herba Asaris, 2～6 parts of Herba Equiseties Hiemalis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010100840A CN101732634A (en) | 2010-01-26 | 2010-01-26 | Chinese medicament for treating silicosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201010100840A CN101732634A (en) | 2010-01-26 | 2010-01-26 | Chinese medicament for treating silicosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101732634A true CN101732634A (en) | 2010-06-16 |
Family
ID=42457002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201010100840A Pending CN101732634A (en) | 2010-01-26 | 2010-01-26 | Chinese medicament for treating silicosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101732634A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824568A (en) * | 2011-06-19 | 2012-12-19 | 孙斌 | Traditional Chinese medicine for treating silicosis |
| CN104383014A (en) * | 2014-11-28 | 2015-03-04 | 朱蕾 | Medicinal composition for treating pneumoconiosis and method for preparing same |
-
2010
- 2010-01-26 CN CN201010100840A patent/CN101732634A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102824568A (en) * | 2011-06-19 | 2012-12-19 | 孙斌 | Traditional Chinese medicine for treating silicosis |
| CN102824568B (en) * | 2011-06-19 | 2014-11-05 | 师厚刚 | Traditional Chinese medicine for treating silicosis |
| CN104383014A (en) * | 2014-11-28 | 2015-03-04 | 朱蕾 | Medicinal composition for treating pneumoconiosis and method for preparing same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102743737B (en) | Chinese medicinal preparation for effectively treating tracheitis | |
| CN101028507A (en) | Chinese-medicinal composition for treating asthma | |
| WO2021208335A1 (en) | Traditional chinese medicine composition capable of removing toxins, dispelling dampness, and disinhibiting throat, and application thereof | |
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN103330826B (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN104042767B (en) | A kind of pharmaceutical composition for the treatment of chronic pharyngitis and its production and use | |
| CN103169908B (en) | Cough and asthma relieving syrup and preparation method thereof | |
| CN103071120B (en) | Medicine for treating silicosis | |
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN104800549A (en) | Traditional Chinese medicine composition for treating chronic bronchitis | |
| CN101732634A (en) | Chinese medicament for treating silicosis | |
| CN102406808A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN101380411A (en) | Traditional Chinese medicine preparation for relieving cough and reducing sputum | |
| CN105833034A (en) | Traditional Chinese medicine composition | |
| CN105343344A (en) | Yin and lung nourishing formula for treating silicosis and preparation method | |
| CN104873862A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN104800570A (en) | Chinese herbal preparation for treating pneumonia | |
| CN102225119A (en) | Medicine for treating headache and preparation method thereof | |
| CN105878996A (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN105031556A (en) | Chinese herb preparation for treating cough variant asthma | |
| CN104398578A (en) | Astragalus membranaceus capsule used for treating bronchial asthma and capable of diffusing lung and calming panting | |
| CN104258231A (en) | Traditional Chinese medicine composition for treating cough | |
| CN102327467A (en) | Chinese patent medicament and Chinese decoction for treating infant diphtheria | |
| CN102406806B (en) | Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof | |
| CN103432550A (en) | Medicament for treating toothache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100616 |